P. Kent Hawryluk, President & CEO at MBX Biosciences, Inc. (MBX), bought 20,000 shares at $13.64 ($273K) on 2025-10-20, disclosed to the SEC on 2025-10-21.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| MBX | BUY | 2025-02-05 | $535K | — | Filing → |
| GEMP | BUY | 2017-03-14 | $474K | — | Filing → |
| GEMP | BUY | 2016-08-12 | $250K | — | Filing → |